InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated ...
Global military spending recently climbed to record levels, led by the United States, Europe and Asia. Defense stocks, backed by longterm government contracts, can offer relatively stable revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results